Evaluation of the GORE TIGRIS Vascular Stent
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 267 participants.
Also called NCT01576055
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 267 participants
- Sponsor
- Registry
-
NCT01576055
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01576055. Randomized; no masking; primary purpose treatment. Start 2012-04 (registry gives no type); primary completion 2015-08 (actual). Results posted on 2016-10-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the GORE TIGRIS Vascular Stent
- Acronym
- TIGRIS
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- TIGRIS Vascular Stent
- Intervention (Device)
- BARD LifeStent
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct01576055- Content hash
c2207772a682ba36d246fbd4877bd7f5b65810422348bd8901138534d375f582